Participate in a clinical study of THCv to understand the effective dose for consumer products that are well tolerated.
Purpose: to evaluate the safety and tolerability of an investigational product CHI-915 for consumer use that is well tolerated. Participation in the study requires an overnight stay in the Nucleus Network Clinic. Overnight stays: 6 x 1 night stays This study has been approved by an independent ethics committee. Reimbursement for study participation will be provided for time and travel of up to $2,537.50 . Call Andy at 651-332-1810 or register your interest to discuss your eligibility today! |